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Precise Microinjection into Skin Using Hollow
Microneedles
Ping M. Wang1,2, Megan Cornwell2,3, James Hill2,4 and Mark R. Prausnitz1,2
Hollow needles of micron dimensions have previously been fabricated and envisioned for use with transdermal
patches or infusion pumps to achieve painless delivery of drugs to the skin for local and systemic effects
without the need for hypodermic needles. However, little work has been carried out to identify methods to
effectively use hollow microneedles for drug delivery. To address this need, we inserted hollow, glass
microneedles into hairless rat skin in vivo and human cadaver skin in vitro and then imaged infusion of dye
molecules, insulin, polymer microparticles, and cells into the skin by brightfield and fluorescence microscopy.
The depth of needle penetration into skin was controlled by inserting needles with a rotary drilling device,
which enabled localized injection within the epidermis or dermis with 760 mm resolution. Although small
quantities of fluid could be injected after needle insertion into skin, partial retraction of the needle by
withdrawing back 100–300 mm or vibrating the microneedle array dramatically increased infusion flow rate. We
conclude that hollow microneedles can be used for precise microinjection into skin, especially when a single
needle is inserted by rotary drilling and then retracted part way before infusion or a microneedle array is
inserted by mechanical vibration.
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INTRODUCTION
Clinical and research applications require delivery of
compounds into skin for local dermatological effects or
systemic effects after absorption into the bloodstream via
dermal capillaries. Drugs and other compounds are usually
delivered to the skin by passive mechanisms, where a
topical formulation or patch is applied to the skin surface
and the drug compound diffuses into the skin across
stratum corneum.
As the stratum corneum’s barrier properties severely limit
passive delivery of most drugs, and especially macromole-
cules and microparticles, intradermal injection using a
hypodermic needle is an effective alternative. However, the
pain and inconvenience of intradermal injection generally
precludes self-administration by patients or other uses outside
the clinic or laboratory. Moreover, the relatively large size of
hypodermic needles and their relatively poorly controlled
manual insertion into skin makes targeted delivery to sites
within skin difficult.
Alternative methods of delivery into skin have been
developed to more effectively drive drugs across stratum
corneum without the use of a needle (Prausnitz et al., 2004;
Bronaugh and Maibach, 2005). Iontophoresis, electropora-
tion, ultrasound, thermal ablation, particle bombardment,
and other methods have received considerable interest, but
have yet to make significant clinical impact. Moreover, other
than the possible exception of particle bombardment
(Burkoth et al., 1999), these methods do not address
intracutaneous targeting.
Recently, arrays of needles measuring just microns in
dimensions have been fabricated by adapting techniques
borrowed from the microelectronics industry (McAllister
et al., 2000; Prausnitz, 2004; Reed and Lye, 2004). These
microneedles have been shown to increase skin permeability
to drugs and particles by orders of magnitude in vitro
(McAllister et al., 2003; Chabri et al., 2004). In vivo animal
studies have shown delivery of insulin (Gardeniers et al.,
2003; Martanto et al., 2004; Davis et al., 2005), oligonucleo-
tides (Lin et al., 2001), human growth hormone (Cormier and
Daddona, 2003), and desmopressin (Cormier et al., 2004), as
well as ovalbumin (Matriano et al., 2002), DNA (Mikszta
et al., 2002) and anthrax (Mikszta et al., 2005) vaccines.
Human studies demonstrated that microneedles can be
inserted painlessly into the skin (Kaushik et al., 2001; Mikszta
et al., 2002).
Although significant attention has been given to fabrica-
tion of both solid and hollow microneedles, most drug
delivery studies have employed just solid microneedles used
either to pierce holes in the skin as a pretreatment before
application of a transdermal patch or coated with drug that
dissolves off the needles upon insertion into the skin. Hollow
microneedles have been shown to deliver pharmacologically
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active insulin to diabetic rats (Gardeniers et al., 2003;
McAllister et al., 2003). In these studies, only systemic effects
were measured, whereas delivery and transport within the
skin were not addressed.
Hollow microneedles have received less attention in part
because they are harder to use. Hollow microneedles are
inherently weaker than solid microneedles and therefore
have additional constraints on needle design and insertion
methods (Davis et al., 2004). Placement of the bore opening
at the needle tip reduces needle tip sharpness and makes
insertion into skin more difficult. Flow through the bore of
hollow microneedles is also difficult to achieve, probably
owing to the resistance to flow provided by dense
dermal tissue beneath the microneedle tip and blockage
owing to possible tissue coring within the needle bore
(Martanto et al., 2006).
Given these challenges, the goal of this study was to
develop a microneedle design and insertion protocol that
pierces microneedles into the skin in a controlled manner
and allows precise microinjection at controlled locations
within the skin and at controlled rates of fluid flow. Spatial
targeting of microinjection is desirable for clinical applica-
tions that seek to target vaccines to epidermal Langerhans
cells, systemic drugs to the superficial dermal capillary bed,
or local drugs to the deeper dermis to minimize systemic
absorption. Spatially targeted delivery is also desirable for
research applications that seek to selectively deliver macro-
molecules, particles used as drug carriers, or possibly cells to
different regions of the skin.
As a model for microfabricated, hollow, metal micro-
needles suitable for mass production, this study used hollow,
glass microneedles, which are easily fabricated for small-
scale research purposes and have a transparent wall that
facilitates viewing inside the lumen. Such micropipettes are
extensively used in cellular physiology, genetics, and
neurophysiology to microinject substances into cells, extract
fluid, or record electrical activity for a variety of different
experimental purposes (Brown and Flaming, 1987). By using
this widely available method of making microneedles,
researchers without access to sophisticated microfabrication
facilities can reproduce our results for their own applications,
whereas those interested to develop microfabricated devices
can be guided by microneedle design and applications
evaluated in this study.
RESULTS
Controlled microneedle insertion and injection into skin
To insert microneedles in a controlled manner into the skin of
hairless rats in vivo and human cadaver skin in vitro, we
developed a hand-operated, rotary penetration device that
drilled individual microneedles into the skin to a predeter-
mined depth regulated by the number of turns of the device.
This rotary drilling approach was designed to reduce the
force of insertion into skin, based on the expectation that
drilling insertion should cause less skin deformation
than direct penetration. After insertion in this manner, the
glass microneedles were found to be mechanically robust;
needles could be inserted into the skin repeatedly (i.e., 410
times) without damage to the needle, as determined by
microscopy.
The hole punctured in the skin by microneedles could be
viewed after inserting and removing the microneedle. When
viewed in situ from the skin surface of a hairless rat, holes
with diameters ranging from 100 to 300 mm were imaged by
microscopy (e.g., Figure 1a). These holes on the surface on
hairless rat skin disappeared within 10–20 minutes in vivo,
based on visual observation through a stereomicroscope.
Only mild, localized erythema was observed immediately
after microneedle treatment, which disappeared within
minutes. These kinetics are similar to observations made
in human subjects (Kaushik et al., 2001). Microneedle
insertion and injection caused no significant complications
in the animals.
Histological sectioning of skin in vitro shows the shape
and depth of needle penetration pathways. Figure 1b shows a
series of sequential cross-sectional images taken parallel to
the skin surface, which gives an indication of the pathway
geometry at different depths in the skin. Figure 1c shows a
series of sequential cross-sectional images taken perpendi-
cular to the skin surface and stained with tissue-marking dye
injected by the microneedle. These images show a tapered
pathway with a geometry similar to that of the microneedle.
The rotary drilling method was designed not only to
reduce the force required for penetration into skin but also
to facilitate microinjection at precise locations within the
skin. Figure 2a demonstrates this, where injections were
made at three different predetermined depths within
the dermis of hairless rats in vivo. In this case, injection
depth ranged from just below the dermal–epidermal junction
to the mid-dermis. Injection in this region may be of interest
to target delivery to the rich capillary bed found in the
superficial dermis for uptake and systemic distribution in
the bloodstream. As shown in Figure 2b, even shallower skin
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Figure 1. Imaging of microneedle track pathways when inserted into hairless
rat skin in vivo. (a) Hole in skin imaged in situ on the skin surface of an
anesthetized hairless rat after insertion and removal of a microneedle.
(b) Sequence of H&E-stained histological sections taken parallel to the
surface of in vitro hairless rat skin surface after piercing with a microneedle.
(c) Sequence of H&E-stained histological sections taken perpendicular to the
surface of in vitro hairless rat skin after piercing with a microneedle and
injecting tissue-marking dye. The lower set of images shows areas of dye
staining determined by image processing of the upper set of histological
sections.
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penetration and injection can target delivery to the epidermis,
which may be useful for various dermatological therapies, as
well as for vaccine delivery to Langerhans dendritic cells
found in the epidermis.
To quantify the precision and reproducibility of targeted
insertion, microneedles were inserted into the back skin on
hairless rats in vivo at six predetermined depths over the
range 150–770mm deep (corresponding to 180–1,0801 rota-
tion of the insertion device). Based on three replicates at each
condition, the average standard error was 760 mm on an
absolute basis and 716% on a percent basis. The exact
relationship between rotation of the insertion device and
depth of penetration into the skin is a complex function of
skin mechanical properties, needle geometry, and other
factors. While we were able to insert microneedles to desired
depths under the controlled and reproducible conditions
used in this study, controlled insertion at different skin sites,
using different needle geometries, or other possible variations
will require re-calibration.
Microneedle retraction to increase flow rate into skin
Data presented so far have marked the sites and tracks of
needle penetration, but have not addressed flow of significant
amounts of fluid into the skin. To address this scenario, the
process of microinjection was imaged in situ by piercing
hairless rat cadaver skin from above with a microneedle and
viewing flow of fluorescent solution into the skin from
below in real time. Insertion of a microneedle in this manner
showed local injection of fluorescent solution, consistent
with imaging results above, but flow into skin was slow
(Figure 3a).
We hypothesized that flow might be limited owing to the
inability of fluid to flow out of the needle and into the dense
dermal tissue surrounding the needle tip that was compressed
during needle insertion. Alternatively, dermal tissue might
have penetrated into the needle bore owing to tissue coring.
In either event, pulling the needle part way back could
facilitate microinjection by relieving tissue compression and/
or withdrawing cored tissue from the needle bore. Consistent
with this hypothesis, we found that slightly retracting the
needle had a large effect on flow into skin (Figure 3b). Within
a few seconds, the field of view imaged by the microscope
was filled with fluorescent solution. Macroscopic examina-
tion of the tissue afterwards showed fluorescent solution
infusion over much larger areas, depending on the duration of
microinfusion (data not shown). Absolute quantification of
flow rates in this case was difficult. However, measurements
carried out in human cadaver skin using a similar apparatus
in a separate study measured flow rates of 21–1,130 ml/hour
through individual microneedles, which increased strongly
with microneedle retraction (Martanto et al., 2006).
Microinjection of insulin, microparticles, and cells
Macromolecules, microparticles, and cells can also be
delivered using microneedles. To demonstrate delivery of a
bioactive macromolecule, insulin solution was microinjected
into hairless rat skin in vitro. Using fluorescently labeled
insulin, the drug was observed to distribute throughout the
dermis (Figure 4). Although the injection was at a specific
location within the dermis, the large volume of fluid injected
in this case spread throughout the dermis. Careful examina-
tion shows that there is only weak fluorescence from within
the epidermis, suggesting that insulin had difficulty crossing
the dermal–epidermal junction and remained within the
dermis. This contrasts with microinjection of calcein, which
fluoresced more uniformly in both dermis and epidermis
(data not shown).
As a companion experiment, insulin was microinjected
into the skin of diabetic hairless rats in vivo and blood
glucose concentration was monitored over time. Microinjec-
tion was carried out via microneedle insertion to a depth of
500–800mm and infusing for 30 minutes. Over a 4.5-hour
monitoring period after infusion, blood glucose level dropped
and then plateaued at approximately 25% below pre-
treatment values (Figure 5). This drop was significantly lower
than blood glucose levels in a negative control group
microinjected with saline (Po0.05). The volume of insulin
solution microinjected into diabetic rat skin was 571 ml over
the 30-minute infusion period.
ba
Figure 2. Highly targeted microinjection at various depths within the dermis
and epidermis. H&E-stained histological sections of hairless rat skin
microinjected in vivo with tissue-marking dye at three controlled depths
(arrows) in (a, bar¼100 mm) the dermis and (b, bar¼ 50 mm) localized within
the epidermis.
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b
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Figure 3. Partial microneedle retraction after insertion into skin dramati-
cally increases injection flow rate. Fluorescence micrographs of calcein
microinjection into hairless rat skin in vitro at 10 psi. Images were recorded
every 2 seconds using real-time microscopy. In (a), the microneedle was
inserted to a depth of approximately 800 mm and flow was initiated at the first
frame. No significant change in fluorescence was observed, corresponding to
little or no injection into the skin. In (b), the microneedle was initially inserted
to the same depth, but was then retracted approximately 200 mm before
initiating flow at the first frame. Large increases in fluorescence were
observed, corresponding to rapid infusion into the skin.
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Recognizing that needle retraction can increase micro-
infusion, the insulin delivery experiment was repeated by
inserting microneedles to the same initial depth in the skin
and then retracting by B200mm back toward the skin
surface. As before, blood glucose level dropped after
microinfusion, but this time dropped approximately 70%
below pre-treatment values (Figure 5), which was a sig-
nificantly greater effect than that caused by saline infusion or
insulin infusion without retraction (Po0.05). The volume of
insulin solution microinjected into diabetic rat skin after
needle retraction was 29712 ml over the 30-minute infusion
period. Microinfusion in this manner may find applications
for continuous or intermittent drug delivery from an indwel-
ling microneedle, which could provide an alternative to the
macroscopic catheters currently used for insulin pump
therapy (Lenhard and Reeves, 2001).
Although microneedles are small, their microns dimen-
sions should be large enough to inject cells, which may be of
interest for tissue engineering, stem cells, and other cell-
based therapies, and microparticles, which may be of interest
for controlled release drug delivery. Initial experiments to test
the effects of shear stress experienced by cells during infusion
through microneedles in the absence of skin flowed suspen-
sions of newborn mouse dermal fibroblasts (provided
courtesy of Dr Kurt Stenn, Aderans Research Institute,
Philadelphia, PA) through microneedles at rates up to
100ml/second and showed no significant loss of cell viability.
Follow-on experiments demonstrated microinjection of
2.8-mm polymeric microspheres and Caco-2 human intestinal
epithelial cells into rat skin in vivo (Figure 6). At smaller
injection pressures, microparticles tended to collect near the
needle tip, whereas at larger pressures they filled the needle
track and at still larger pressures they penetrated deeper into
the skin (Figure 7).
Microneedle vibration for injection using microneedle arrays
Although drilling and retraction are effective to control
injection using single microneedles, drilling may be difficult
a b
Figure 4. Microinjection of insulin into skin. Hairless rat skin was
microinjected in vivo with FITC-insulin. Histological sections are shown using
(a) brightfield microscopy with H&E staining and (b) fluorescence microscopy
showing injection and distribution of insulin in the skin. Bar¼100 mm.
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Figure 5. Insulin microinjection modulates blood glucose levels in diabetic
rats. Changes in blood glucose level in diabetic hairless rats before, during,
and after a 30-minute infusion from a microneedle: (m) infusion of saline as a
negative control (n¼ 4), (J) infusion of insulin for microneedle inserted
800mm (n¼3), (K) infusion of insulin solution using microneedle inserted
800mm and then retracted B200 mm (n¼4). Data expressed as mean7SEM.
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Figure 6. Microinjection of polymeric particles and cells into hairless rat
skin in vivo. (a) Brightfield micrograph of H&E-stained histological section of
in vitro hairless rat skin after microinjection with 2.8-mm polymeric
microspheres. Inset shows magnified view of microspheres in skin. (b)
Fluorescence micrograph of histological section of hairless rat skin after in
vivo microinjection of fluorescence-labeled Caco-2 human intestinal
epithelial cells.
2.5 10 20 psi
100 m
Figure 7. Microinjection of polymeric particles at different pressures.
Fluorescence micrographs of histological sections after microinjection of 2.5-
mm fluorescent microspheres into hairless rat skin in vivo under pressures
ranging from 2.5 to 20 psi via the same needle and loading for the same time
periods. The volume and depth of injection increased with increasing
pressure.
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to implement with multi-needle arrays. As an alternative,
microneedle arrays were inserted into skin using vibration
(i.e., without rotary drilling or retraction), which also was
effective to facilitate microinjection. As shown in Figure 8,
injection from a seven-needle array into hairless rat skin
without vibration introduced very little dye into the skin,
whereas injection after insertion using vibration delivered
much more. Although this demonstrates the feasibility of a
vibration-based approach, additional study is needed to
better optimize and evaluate this method.
DISCUSSION
This study introduced the idea of inserting microneedles into
skin using a rotary drilling device to precisely deliver drug
solutions, solid particles, and cells at controlled depths into
epidermis and dermis. This study also demonstrated for the
first time that partial needle retraction after insertion into
the skin or insertion and infusion during mechanical
vibration can dramatically increase microinjection flow rate
into the skin.
Precise microinjection into skin
The ability to precisely inject fluids, macromolecules,
particles, and cells into skin at controlled depths and
controlled amounts is important to a variety of applications.
Dermatological treatments could benefit from intracutaneous
delivery with minimal tissue trauma. The ability to target
specific layers of the skin could also increase treatment
efficacy. Vaccine delivery to the skin has previously been
shown to elicit stronger immune responses than injection into
deeper tissue (Glenn et al., 2003). Delivery to the epidermis
could further target the Langerhans cells believed to be
responsible for the enhanced immune response; alternatively,
dermal dendritic cells could be targeted by controlled
injection into the dermis. Systemic delivery could also benefit
from infusion to the dermal capillary bed for rapid uptake and
distribution. Researchers might also find precise microinjec-
tion into skin useful to develop clinical treatments, as well as
to address mechanistic questions requiring targeting specific
cells or layers of skin.
The hollow, glass microneedles used in this study have
strengths and weaknesses. As a laboratory tool, glass
microneedles offer the advantage of being simple and
inexpensive to make using widely available techniques and
equipment. Glass microneedle strength was increased by
heating the tip to smooth and thicken the wall. Handling was
facilitated by placing needles within a hand-operated drilling
insertion device.
Despite the versatility of microneedles made from glass
pipettes in the laboratory, clinical applications would benefit
from microneedles made from different materials and by
different methods. To address this need, the literature
contains many studies showing how to make microneedles
out of other materials, such as metal, using microfabrication
techniques that could be scaled up for mass production at
disposable cost (McAllister et al., 2000; Prausnitz, 2004;
Reed and Lye, 2004). We performed a preliminary study to
mold microneedles for mass production, as discussed in
Materials and Methods.
Despite impressive fabrication advances, the literature has
offered relatively little information about how to use these
microneedles for medical and other applications. This
study found that drilling insertion and partial needle
retraction can be used to make microneedle injection more
controlled and effective. Drilling was advantageous because
it reduced skin deformation during needle insertion and
thereby provided more control of insertion depth. Although
reduced, there was still some skin deformation during
insertion, so that the insertion depth into skin was only
proportional, but not equal, to the microneedle displacement
distance during insertion. Because insertion of multi-needle
arrays may be difficult using rotary drilling, we found
that microneedle arrays could be effectively inserted
using vibration. In a related study, the insertion force of
microneedles was also reduced using vibration (Yang and
Zahn, 2004)
Partial needle retraction was advantageous because it
increased the flow rate during infusion by many fold. This
indicates that microneedle insertion may compress skin tissue
to form a dense barrier that blocks fluid flow and dispersion at
the microneedle tip. Retracting the microneedle to create a
space for fluid flow and using a beveled microneedle with a
bore opening on the side of the microneedle tip may avoid
the need to force fluid into the compressed tissue layer and
thereby increase the infusion rate.
Imaging methods
Each of the three methods used to image injection have
strengths and weaknesses. Determining injection volume by
measuring the dyed area shown in skin section images using
the magic wand tool of Adobe Photoshop (version 5.0; Adobe
Systems, San Jose, CA) for histological slide imaging or based
on a specified threshold gray level for microtome imaging
assumed that the injected dye was uniformly dispersed in the
skin tissue and there was no loss of dye during the
histological slice preparation. Although microtome imaging
reduced the chance of artifact by avoiding preparation of
histological slides, selecting the gray level threshold strongly
a b
1 mm
Figure 8. Vibration of microneedle arrays during insertion increases
microinjection. Seven-needle arrays of microneedles were inserted
into hairless rat skin in vivo and used to inject tissue-marking dye.
(a) Intracutaneous staining imaged in situ at the skin surface shows little
microinjection when the needle array was inserted without vibration for
10 minutes. (b) Much more dye was injected when the needle array was
vibrated during and for 1 minute after insertion.
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influenced the area calculation and thereby introduced
uncertainty.
Real-time, in situ imaging on the microscope stage further
reduces the chance of artifact owing to sample handling and
also provides a fluorescence measurement that is a direct
measure of volume rather than area from a cross-section of
tissue. This volume measurement, however, is only accurate
for a limited thickness of tissue within the focal range of the
microscope objective. Real-time imaging also facilitates
studying the dynamics of microinjection, which makes this
approach especially attractive.
Conclusions
Hollow, glass microneedles were fabricated using a method
readily reproduced in biomedical laboratories to serve as a
model for microneedles mass produced by microfabrication.
Using a rotary drilling method, microneedles were inserted
into the skin at controlled depths within the epidermis or
dermis. By partially retracting microneedles after insertion,
flow rate into the skin was dramatically increased for delivery
of small dye molecules, insulin, polymer particles, and cells.
This represents the first study to carefully examine needle
insertion and infusion parameters to enable controlled and
targeted intracutaneous delivery using hollow microneedles.
The results suggest applications in dermatological research,
as well as minimally invasive clinical applications for local
and systemic delivery of drugs, vaccines, particles, and cells.
MATERIALS AND METHODS
Microneedle fabrication
Glass microneedles were made using conventional drawn glass
micropipette techniques (Brown and Flaming, 1987). Microneedles
were prepared by pulling glass capillary tubing (OD 1.5 mm, ID
1.1 mm, B150-110-10, borosilicate glass; Sutter Instrument, Novato,
CA) with a puller (P97; Sutter Instrument) that reproducibly pulled
needles with desired geometries according to programmable
parameters. Blunt glass microneedles were fabricated with outer
radii at the tip of 15–40 mm and cone angles of 20–301 (Figure 9a).
We further used a needle beveller (BV-10; Sutter Instrument) to grind
the needle tip, which was then briefly heated to smooth the surface
and produce a beveled tip with a side-opening bore having an oval
geometry with a short ellipsoidal axis of 60–110 mm and a long
ellipsoidal axis of 80–160mm (Figure 9b). Microneedles were
cleaned sequentially with a chromic acid cleaning solution (Klean
AR; Mallinckrodt, Phillipsburg, NJ), water, and acetone.
To increase their strength, microneedle tips were quickly heated
using a Bunsen burner for 1–2 seconds to smooth and thicken the
needle wall at the tip. Microneedles were also sometimes assembled
into seven-needle bundles using epoxy resin (Polypoxy 1010;
Polytek, Easton, PA) to form multi-needle arrays (Figure 10a and
b). Microneedle geometry was imaged and measured by micro-
scopy. The occasional microneedles that were misformed or
contaminated with debris were discarded.
To demonstrate polymer molding of microneedles for inexpen-
sive mass production, polymer microneedles were fabricated by first
making a mold out of polydimethylsiloxane (Sylgard 184; Dow
Corning, Midland, MI) from a master array of glass microneedles and
then using the mold to make replicate arrays of polymer
microneedles by casting with poly-glycolide or poly-lactide-
co-glycolide (Absorbable Polymers International, Pelham, AL; Park
et al., 2005; Figure 10c and d).
Skin models
The in vitro skin model was full-thickness human cadaver skin,
which was obtained from the Emory University Body Donor Program
with approval from the Georgia Institute of Technology and Emory
University Institutional Review Boards and used according to the
Declaration of Helsinki Principles. Skin samples were stored at
701C and thawed to room temperature before use. The in vivo skin
model was healthy, anesthetized, adult, male, Sprague–Dawley
hairless rats (weighing 280–410 g; Charles River Laboratories,
Wilmington, MA) handled with approval from the Georgia Institute
of Technology Institutional Animal Care and Use Committee. For
short experiments (o1 hour), animals were anesthetized by intraper-
itoneal injection of pentobarbital sodium (60 mg/kg). Additional
anesthetic was given according to the animals’ depth of anesthesia
determined by pedal reflex. At the end of experiments, animals were
euthanized with intraperitoneal injection of beuthanasia (390 mg
pentobarbital sodiumþ 50 mg phenytoin sodium/ml, 1 ml/10 lb body
a b
Figure 9. Hollow, glass microneedles used for microinjection. (a) Micro-
needle with a bore opening at a blunt tip. (b) Microneedle with a side-opening
bore at a beveled tip. Bar¼100 mm.
a
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Figure 10. Images of multi-needle glass and polymer microneedle arrays.
(a, b) Glass microneedles assembled into an array using epoxy. (c) Poly-
glycolide polymer microneedle and (d) poly-lactide-co-glycolide polymer
microneedle array molded from glass microneedle masters. Bars¼100 mm.
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weight). Experimental skin specimens were harvested post mortem
for histological analysis.
To test the ability of microneedles to deliver insulin to lower
blood glucose levels in diabetic animals, we created diabetic rat
models as described previously (Martanto et al., 2004). In brief,
hairless rats were injected intravenously through the tail vein with
100 mg/kg streptozotocin (Sigma, Milwaukee, WI), which destroyed
their pancreatic islet cells (Haughton et al., 1999). Induction of
diabetes was verified by measuring blood glucose levels of
350–500 mg/dl (Accu-chek Compact blood glucose meter; Roche
Diagnostics, Basel, Switzerland). During insulin delivery experi-
ments, rats were anesthetized by intraperitoneal injection of
urethane (200 mg/ml in phosphate-buffered saline (PBS), 1.3 g/kg;
Sigma), which provided deep anesthesia for many hours.
Microinjection into skin
Single, hollow, glass microneedles were inserted into the back skin
of anesthetized rats placed in a prone position or into human
cadaver skin (2 2 cm2) placed on a x–y stage. Compounds
delivered included blue tissue-marking dye in PBS (20% (v/v);
Shandon, Pittsburg, PA), green fluorescent calcein in PBS
(10 mM–10 mM; Molecular Probes, Eugene, OR), clinical insulin
solution (100 U/ml; Humulin R, Eli Lilly, Indianapolis, IN), FITC-
labeled insulin in PBS (1 mg/ml; Sigma), polymeric microparticles in
PBS (2.8 mm diameter, B2 mg/ml, Epoxy beads M-270 (Dynal
Biotech, Brown Deer, WI) or 2.5mm diameter, 1–2% solids,
carboxylate-modified FluoSpheres, yellow-green fluorescent (Mole-
cular Probes)), or Caco-2 intestinal epithelial cells (3–5 106 cells/
ml; American Type Culture Collection, Manassas, VA) labeled with a
fluorescent dye (Hoechst 33258; Molecular Probes).
Microneedles were first filled from the distal end with the above
solutions or suspensions using a conventional hypodermic needle
(25–31 G; Becton Dickinson, Franklin Lakes, NJ); a thin filament
manufactured inside the microneedle lumen enhanced liquid flow to
the proximal/tip end of the microneedle and displace air bubbles.
Microneedles were connected via tubing to a cylinder of compressed
CO2, which drove microinfusion at regulated pressures of 5–20 psi
for delivery durations of 5–30 minutes.
Microneedles were mounted in a rotary drilling device, which
controlled axial translation of the microneedle tip with 710 mm
accuracy during drilling into the skin. Device calibration by
microscopy determined that every 3601 rotation of the drilling
device moved the microneedle tip 1,200mm in its axial direction.
However, owing to skin deformation during insertion, microneedle
insertion depth into the skin was onlyB800mm under the conditions
used in this study, as determined by subsequent histological
examination of skin samples. The amount of this deformation was
limited not only by the drilling method of insertion, but also by
pressing the convex base of the insertion device firmly against the
skin surface, which held the skin in place. Before conducting in vivo
experiments, the insertion device was sterilized by autoclave
(AMSCO Scientific Series 3021-S, Erie, PA).
Because it is difficult to insert multi-needle arrays by rotary
drilling, microneedle arrays were inserted using a device that
vibrated the needle during insertion and injection into skin. The
vibration motor operated at a vibration frequency of 24 Hz with an
amplitude of 100 mm parallel to the needle axis. These frequency
and displacement values were selected based on the convenient
availability of a motor with these specifications and have not been
optimized. Note that although the oscillatory vibration amplitude
during manual insertion was 100 mm, needles were inserted to a net
displacement much deeper.
Histological preparation
After microinfusion experiments, skin samples were harvested from
the human cadaver skin or animals post mortem and embedded in
optimal cutting temperature compound (Tissue-Tek, Sakura Finetek,
Torrance, CA) within an embedding mold cup. After rapidly freezing
in liquid nitrogen, skin samples were sectioned into 10- to 14-mm
thick slices using a cryostat microtome (HM 560; Microm Interna-
tional, Richard-Allan Scientific, Kalamazoo, MI). The cryosection
slides were stained with hematoxylin and eosin (H&E) using an
autostainer (XL, Leica, Nussloch, Germany).
Microscopic imaging
Imaging of holes on the skin surface and within the skin made by
microneedles as well as imaging of fluorescently tagged compounds
injected into the skin was performed using either a stereoscopic
(SZX12; Olympus, Melville, NY) or an inverted fluorescence
microscope (IX 70; Olympus) with a digital camera (Spot RT Slider
camera, Model 231; Diagnostic Instruments, Sterling Heights, MI).
Images were analyzed using image analysis software (Image Pro
Plus, version 4.5; Media Cybernetics, Silver Spring, MD). The
volume of injected liquid was imaged in the skin for quantitative
analysis using one of three different methods.
The first method was derived from a technique developed to
quantify the distribution volume after injection into solid tumors
(McGuire and Yuan, 2001). In brief, immediately after microinjection
of a blue-green tissue-marking dye solution, skin specimens were
frozen in liquid nitrogen and sectioned using a cryostat microtome.
The skin slices were imaged by digital microscopy to determine the
area stained by the dye. Multiplying this area by the skin section
thickness provided a volume. Summing the volumes from all skin
sections containing dye yielded the total injected volume.
For the second method, we positioned a mini-video camera at the
microtome stage oriented perpendicularly to the sectioning surface
of the skin specimen (Figure 11a). Eliminating the time-consuming
preparation and imaging of histological slides, as well as the possible
loss during the slide preparation of dye delivered into the skin
samples, we instead used the video camera (with a resolution of
640 480 pixels) to directly image each sectioned skin slice on the
microtome. The images were stored in a computer for further
analysis and the skin sections were discarded. The total injected
volume was calculated as described above, based on the dyed area
and skin section thickness.
During microtome imaging, illumination of the skin specimen
was kept constant and the video camera was not moved. To account
for different lighting conditions during imaging on the microtome
and imaging histological slides, the gray threshold that determined
the area of skin considered stained with dye by microtome imaging
was selected to yield, on average, the same area acquired by
histological imaging.
As a third method, we imaged microinfusion into skin in situ in
real time. A microneedle filled with fluorescent dye solution of
calcein was rotary drilled 500–1,000mm into a piece of skin (1 cm2)
placed with the stratum corneum side facing up on a glass slide
1086 Journal of Investigative Dermatology (2006), Volume 126
PM Wang et al.
Microinjection Using Hollow Microneedles
mounted on the stage of an inverted microscope in a darkened room
(Figure 11b). The microscope was focused on the tip of the
microneedle and a time series of images was collected every
2 seconds while infusing calcein solution at a pressure of 10 psi.
The relative infusion rate over time was determined by assuming
that fluorescence measured in the images was proportional to the
injected volume. To express the injected volume on an absolute
basis, we determined the total injected liquid volume by measuring
the change in weight of the liquid-filled microneedle before and after
the injection assuming a liquid density of 1 g/ml using a balance with
a sensitivity of 70.1 mg.
Statistical analysis
All data are presented as mean7standard error of the mean.
Student’s t-test was used to assess statistically significant differences.
Comparisons between group means were carried out using analysis
of variance. Mean values were considered significantly different if
Po0.05. An unpaired t-test was used to determine the significance of
the differences of blood glucose levels caused by microinjection of
insulin and saline in different animals. All statistical analyses were
performed using Statview (SAS Institute, Cary, NC).
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Figure 11. Microscopic methods to image microinjection into skin.
(a) Scheme of the direct-imaging method using a video-microscopy system
focused on a cryostat microtome to image the dyed area in each skin cross-
section. (b) Scheme of the in situ imaging of transdermal microinjection in
real time using skin placed on the stage of an inverted microscope.
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